MoneyWorks4Me

Orchid Pharma - Quaterly Results

12 Aug 2024 Evaluate
The sales moved up 33.61% to Rs. 2444.06 millions for the June 2024 quarter as compared to Rs. 1829.20 millions during the year-ago period.The Total revenue for the quarter ended June 2024 of  Rs. 291.03  millions  grew by 170.10% from Rs. 107.75 millions.The company reported a good operating profit of 410.20 millions compared to 240.28 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 2444.06 1829.20 33.61 2444.06 1829.20 33.61 8193.68 6658.98 23.05
Other Income 77.72 18.86 312.09 77.72 18.86 312.09 303.89 194.30 56.40
PBIDT 410.20 240.28 70.72 410.20 240.28 70.72 1410.70 1030.49 36.90
Interest 34.73 55.45 -37.37 34.73 55.45 -37.37 163.28 322.26 -49.33
PBDT 375.47 184.83 103.14 375.47 184.83 103.14 1247.42 1100.33 13.37
Depreciation 84.44 77.08 9.55 84.44 77.08 9.55 332.19 547.87 -39.37
PBT 291.03 107.75 170.10 291.03 107.75 170.10 915.23 552.46 65.66
TAX 0.00 0.00 0.00 0.00 0.00 0.00 -32.26 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -32.26 0.00 0.00
PAT 291.03 107.75 170.10 291.03 107.75 170.10 947.49 552.46 71.50
Equity 507.19 507.19 0.00 507.19 507.19 0.00 507.19 408.16 24.26
PBIDTM(%) 16.78 13.14 27.77 16.78 13.14 27.77 17.22 15.48 11.25
Peers
Company Name CMP
Sun Pharma. Inds. 1851.50
Dr. Reddys Labs. 1140.50
Cipla 1357.95
Lupin 2041.60
Zydus Lifesciences 1098.40
View more..